Cart
sales@molnova.com
GPR35 agonist 3
CAS No. 123021-85-2
GPR35 agonist 3( —— )
Catalog No. M36473 CAS No. 123021-85-2
GPR35 agonist 3 is a synthetic GPR35 agonist with an EC50 value of 1.4 μg in the β-arrestin recruitment assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 64 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 296 | In Stock |
|
| 50MG | 476 | In Stock |
|
| 100MG | 743 | In Stock |
|
| 500MG | 1485 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGPR35 agonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionGPR35 agonist 3 is a synthetic GPR35 agonist with an EC50 value of 1.4 μg in the β-arrestin recruitment assay.
-
DescriptionGPR35 agonist 3 is a synthetic GPR35 agonist with an EC50value of 1.4 μM. GPR35 agonist 3 can be used for the research of various diseases, such as gastric cancer, type 2 diabetes, cardiovascular diseases, immune system and peripheral nervous system.
-
In VitroGPR35 agonist 3 shows GPR35 agonist potency with an EC50 value of 1.4 μM.GPR35 agonist 3 has affinity and potency for GPR35 with values of 0.0508μM (Ki) and 0.349 μM (IC50).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorArrestin | GPR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123021-85-2
-
Formula Weight279.27
-
Molecular FormulaC12H9NO5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)COC1=CC=C(\C=C2\SC(=O)NC2=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dominik Thimm, et al. 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: a powerful tool for studying orphan G protein-coupled receptor GPR35. J Med Chem?
molnova catalog
related products
-
Pelargonidin-3-O-rut...
Pelargonidin 3-Rutinoside exhibits antioxidant and anti-inflammatory properties.
-
BDA 366
BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.
-
DO-264
DO-264 is an inhibitor of autohydrolase structural domain 12 (ABHD12) (IC50: 11 nM) and an inhibitor of cellular LysoPS degradation that enhances LPS-induced phagocytosis.
